Source: Eur Respir J, 56 (2) 1902295; 10.1183/13993003.02295-2019
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Silke Ryan, Eoin P. Cummins, Ramon Farre, Alex Gileles-Hillel, Jonathan C. Jun, Henrik Oster, Jean-Louis Pepin, David W. Ray, Sirimon Reutrakul, Manuel Sanchez-de-la-Torre, Renaud Tamisier, Isaac Almendros. Understanding the pathophysiological mechanisms of cardiometabolic complications in obstructive sleep apnoea: towards personalised treatment approaches. Eur Respir J, 56 (2) 1902295; 10.1183/13993003.02295-2019

Member's Comments

No comment yet.

Related content which might interest you: Molecular mechanisms underlying metabolic comorbidities in patients with obstructive sleep apnoea Source: Sleep and Breathing Conference 2021 Year: 2021 Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities Source: Eur Respir J 2007; 29: 156-178 Year: 2007 The genetic and cardiovascular aspects of obstructive sleep apnoea/hypopnoea syndrome Source: Eur Respir J 2009; 33: 233-236 Year: 2009 The puzzle of metabolic effects of obstructive sleep apnoea in children Source: Eur Respir J 2016; 47: 1050-1053 Year: 2016 Diet and exercise in the management of obstructive sleep apnoea and cardiovascular disease risk Source: Eur Respir Rev, 26 (144) 160110; 10.1183/16000617.0110-2016 Year: 2017 Combination between sleep apnoea and COPD: a synergistic risk for cardiovascular diseases? Source: Sleep and Breathing Conference 2017 Year: 2017 Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Personalised medicine in sleep respiratory disorders: focus on obstructive sleep apnoea diagnosis and treatment Source: Eur Respir Rev, 26 (146) 170069; 10.1183/16000617.0069-2017 Year: 2017 The metabolic consequences of obstructive sleep apnoea in children Source: Breathe 2009; 6: 111-114 Year: 2009 Cardiovascular and metabolic consequences of obstructive sleep apnoea Source: Eur Respir J 2001; 18: Suppl. 33, 519s Year: 2001 Techniques for predicting outcome of therapeutic interventions in respiratory disorders during sleep Source: Annual Congress 2007 - PG21 - Diagnostic and therapeutic aspects of respiratory disorders during sleep Year: 2007 The effects of obstructive sleep apnea syndrome on cognitive and cardiovascular functioning in children with obesity Source: Annual Congress 2012 - Sleep monitoring, lung function and inflammation in childhood Year: 2012 Gender differences in global cardiovascular risk factors of obstructive sleep apnea patients Source: Eur Respir J 2006; 28: Suppl. 50, 413s Year: 2006 Effect of continuous positive airway pressure therapy on metabolic control in patients with morbid obesity and obstructive sleep apnoea Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing Year: 2013 The role of inflammatory biomarkers in obstructive sleep apnea syndrome Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality Year: 2018 Personalised approach to treatment of children with obstructive sleep apnoea: what is the evidence? Source: Sleep and Breathing Conference 2021 Year: 2021 Perioperative screening for obstructive sleep apnoea and treatment outcomes: where are the data? Source: Eur Respir J 2016; 48: 21-22 Year: 2016 A review of psychosocial factors and personality in the treatment of obstructive sleep apnoea Source: Eur Respir Rev, 28 (152) 190005; 10.1183/16000617.0005-2019 Year: 2019